ÈËÆÞÖгöÊÓƵ

Skip to main content

Jason Hunt, MD, Announced as Interim Chair for New Department of Otolaryngology

Read Time: 2 minutes

White man names Jason Hunt wearing a white lab coat over a white button up and blue tie standing in front of bookshelves
Jason Hunt, MD, FACS
Jason Hunt, MD, FACS, clinical director of head and neck surgical oncology at Huntsman Cancer Institute, has been named the interim chair of the ÈËÆÞÖгöÊÓƵ of Utah ÈËÆÞÖгöÊÓƵ (U of U ÈËÆÞÖгöÊÓƵ) Department of Otolaryngology – Head and Neck Surgery (OHNS). The new department will continue to promote collaboration and research between Huntsman Cancer Institute and U of U ÈËÆÞÖгöÊÓƵ.

Hunt began his new role on October 1, 2022. He has been with Huntsman Cancer Institute since 2006, specializing in melanoma, thyroid cancer, and throat cancer. Hunt served as medical director of Huntsman Cancer Institute operating rooms. His colleagues appreciate his leadership and passion for patient-centered care in all his roles.

"Dr. Hunt is a fantastic leader," says Sachin Apte, MD, MS, MBA, chief clinical officer and physician-in-chief at Huntsman Cancer Institute. "His new role will foster collaboration, research, and clinical innovation throughout Huntsman Cancer Institute and U of U ÈËÆÞÖгöÊÓƵ."

"All members of OHNS are excited for this transition and look forward to continued growth and success in all of our missions," says Hunt. "This achievement was made possible by all the members of our group and their dedication to patient care, education, and discovery. I couldn't be happier for all our faculty, staff, and trainees. I am honored and humbled to lead such an amazing team of accomplished individuals as interim chair."

Media Contact

Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu

About Huntsman Cancer Institute at the ÈËÆÞÖгöÊÓƵ of Utah

Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.

Resources for Media

Cancer touches all of us.